Summary
Elevance Health, Inc. (ELV), formerly Anthem, Inc., filed an 8-K on March 15, 2017, primarily to provide updated financial guidance. The company reaffirmed its net income guidance for the full year 2017, expecting it to be greater than $11.11 per share. This includes an expectation of greater than $0.39 per share in net unfavorable items. Excluding these specific items, the company anticipates adjusted net income to be greater than $11.50 per share. This guidance explicitly excludes several potential financial impacts, including benefits or costs related to the pending acquisition of Cigna Corporation, liabilities from state guaranty association assessments (specifically related to Penn Treaty Network America Insurance Company), investment gains or losses, other than temporary impairment losses, and amortization of other intangible assets. Investors should note that this guidance does not incorporate the significant potential financial implications of the ongoing Cigna acquisition, which was subject to litigation and regulatory review at the time.
Key Highlights
- 1Reaffirmed Full-Year 2017 Net Income Guidance: Greater than $11.11 per share.
- 2Projected Adjusted Net Income: Greater than $11.50 per share, excluding specific items.
- 3Exclusion of Cigna Acquisition Costs/Benefits: Guidance does not include any financial impact from the pending Cigna acquisition.
- 4Exclusion of State Guaranty Association Assessments: Liabilities related to Penn Treaty Network America Insurance Company's liquidation are excluded.
- 5Exclusion of Investment and Intangible Asset Impacts: Gains/losses, impairment losses, and amortization of intangibles are excluded from adjusted net income.
- 6Regulation FD Disclosure: Information provided in Item 7.01 is not deemed 'filed' for Section 18 purposes.
- 7Forward-Looking Statements Caution: The report includes standard cautionary language regarding forward-looking statements and associated risks.